5,6-Dimethylpyrazine-2,3-dicarbonitrile

Catalog No. :
ACTDCV851
CAS No. :
40227-17-6
Molecular Formula :
C8H6N4
Molecular Weight :
158.16

IUPAC Name:5,6-dimethylpyrazine-2,3-dicarbonitrile

5,6-Dimethylpyrazine-2,3-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$66.00Login to see priceIn stockIn stock
5g98%$241.00Login to see priceIn stockIn stock
25g98%$680.00Login to see priceIn stockInquiry
100g98%$2101.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,6-Dimethylpyrazine-2,3-dicarbonitrile
IUPAC Name5,6-dimethylpyrazine-2,3-dicarbonitrile
MDL No.MFCD00192087
Molecular FormulaC8H6N4
Molecular Weight158.16
SMILESN#CC1=NC(C)=C(C)N=C1C#N
InChI KeyVPRRXMCIOHZBCX-UHFFFAOYSA-N
Synonym5,6-Dimethyl-2,3-pyrazinedicarbonitrile 99%;AKOS BBS-00003128;5,6-DIMETHYL-2,3-PYRAZINEDICARBONITRILE;5,6-dimethylpyrazine-2,3-dicarbonitrile;2,3-Pyrazinedicarbonitrile, 5,6-dimethyl-;5,6-dimethyl-2,3-pyrazine formaldehyde
CAS No.40227-17-6
PubChem CID299559

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTDCV851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDCV851 route product structure diagram
    ACTDCV85140227-17-6 In Stock
Inquiry

2. ACTDCV851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACTDCV851 route product structure diagram
    ACTDCV85140227-17-6 In Stock
Inquiry

Comments (0)